ARATECAN
Live / Applied — Non-final action mailed (as of 02 Jul 2026)
What this means for you
Not registered yet, but its 15 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79448735
- Mark type
- Word mark
- Filed
- 15 Dec 2025
Goods and services
- Class 001 — Chemicals: Peptides, peptide derivatives, proteins, glycans, lipids, active principle antibody conjugates, antibody fragments, antibody derivatives, vectors for scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely, polypeptides, peptide derivatives for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for manufacturing pharmaceutical products.
- Class 005 — Pharmaceuticals: Pharmaceutical products and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular and biochemical genetic and biopharmaceutical products for medical and pharmaceutical use, namely peptides, peptide derivatives, active principle antibody conjugates, antibody fragments, antibody derivatives, vectors; pharmaceutical products and substances for disease treatment and preparations for medical treatments.
- Class 035 — Advertising and business services: Provision of information with respect to business contacts for research projects.
- Class 042 — Scientific and technological services: Scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; biochemical or pharmaceutical laboratory services; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results.
Owner
Prosecution history
- 16 Jul 2026 — REFUSAL PROCESSED BY IB
- 02 Jul 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 02 Jul 2026 — REFUSAL PROCESSED BY MPU
- 12 May 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 11 May 2026 — NON-FINAL ACTION WRITTEN
- 25 Apr 2026 — ASSIGNED TO EXAMINER
- 24 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 24 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Apr 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB